How to buy Morphic Holding stock
Learn how to easily invest in Morphic Holding stock.
Morphic Holding is a biotechnology business based in the US. Morphic Holding shares (MORF) are listed on the NASDAQ and all prices are listed in US Dollars. Morphic Holding employs 110 staff and has a trailing 12-month revenue of around $8.7 million.
How to buy Morphic Holding stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – MORF. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Morphic Holding stock price (NASDAQ: MORF)Use our graph to track the performance of MORF stocks over time.
Morphic Holding shares at a glance
|Latest market close||$22.82|
|52-week range||$21.18 - $63.08|
|50-day moving average||$56.07|
|200-day moving average||$44.25|
|Wall St. target price||$74.78|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-3.26|
Buy Morphic Holding stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Morphic Holding stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Morphic Holding price performance over time
|1 week (2023-09-21)||-55.60%|
|1 month (2023-08-28)||-58.34%|
|3 months (2023-06-28)||-59.92%|
|6 months (2023-03-28)||-39.02%|
|1 year (2022-09-28)||-20.68%|
|2 years (2021-09-28)||-62.83%|
|3 years (2020-09-28)||26.9|
|5 years (2018-09-24)||N/A|
Morphic Holding financials
|Revenue TTM||$8.7 million|
|Gross profit TTM||$-31,254,000|
|Return on assets TTM||-15.33%|
|Return on equity TTM||-23.19%|
|Market Capitalization||$2.7 billion|
TTM: trailing 12 months
Morphic Holding share dividends
We're not expecting Morphic Holding to pay a dividend over the next 12 months.
Morphic Holding share price volatility
Over the last 12 months, Morphic Holding's shares have ranged in value from as little as $21.18 up to $63.0825. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Morphic Holding's is 1.0939. This would suggest that Morphic Holding's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Morphic Holding overview
Morphic Holding, Inc. , a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company's products in pipeline include Next Gen a4ß7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc. ; avß8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrödinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Morphic Holding in the news
Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence
Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023
Frequently asked questionsWhat percentage of Morphic Holding is owned by insiders or institutions?
Currently 16.64% of Morphic Holding shares are held by insiders and 73.028% by institutions. How many people work for Morphic Holding?
Latest data suggests 110 work at Morphic Holding. When does the fiscal year end for Morphic Holding?
Morphic Holding's fiscal year ends in December. Where is Morphic Holding based?
Morphic Holding's address is: 35 Gatehouse Drive, A2, Waltham, MA, United States, 02451 What is Morphic Holding's ISIN number?
Morphic Holding's international securities identification number is: US61775R1059 What is Morphic Holding's CUSIP number?
Morphic Holding's Committee on Uniform Securities Identification Procedures number is: 61775R105
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert